Bibliographic Details
| Title: |
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients. |
| Authors: |
Correale P; Translational Immuno-Oncology Unit, Medical Oncology Section, Department G. Segre of Pharmacology, Siena University School of Medicine, Siena, Italy., Remondo C, Carbone SF, Ricci V, Migali C, Martellucci I, Licchetta A, Addeo R, Volterrani L, Gotti G, Rotundo MS, Tassone P, Sperlongano P, Abbruzzese A, Caraglia M, Tagliaferri P, Francini G |
| Source: |
Cancer biology & therapy [Cancer Biol Ther] 2010 May 01; Vol. 9 (9), pp. 685-93. |
| Publication Type: |
Clinical Trial, Phase I; Journal Article |
| Journal Info: |
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
